G1 Therapeutics to Ring Nasdaq Stock Market Closing Bell on Wednesday, August 2, 2017
The bell ringing will celebrate G1’s
“G1’s listing on the Nasdaq is a significant corporate milestone, and we’re honored to be invited by Nasdaq to celebrate the hard work that enabled us to become a publicly traded company,” said Velleca. “Since our first round of funding four years ago, G1 has grown from a small group of scientists to more than 35 team members dedicated to developing new and improved therapies for the treatment of cancer. Our public offering will enable us to advance our clinical development programs and expand our pipeline of innovative therapies to address unmet needs in patients with cancer.”
A live webcast of the ceremony will begin at
About Nasdaq
About
G1 is based in Research Triangle Park, NC. For additional information about G1, please visit www.g1therapeutics.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on G1 Therapeutics’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause G1 Therapeutics’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in G1 Therapeutics’ filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" sections contained therein. Except as required by law, G1 Therapeutics assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.
Contacts: Investors:Robert Uhl Westwicke Partners 858-356-5932 robert.uhl@westwicke.com Media: Laura Bagby 6Degrees Communications 312-448-8098 lbagby@6degreespr.com